The prospective, double-blind, randomized controlled trial (RCT) enrolled 244 patients to evaluate the Butterfly Prostatic Retraction Device, a minimally invasive, reversible implant that mechanically ...

Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.

Butterfly Medical announced that it completed the final 12-month follow-up for all patients in a study of its prostatic ...

Procept BioRobotics Corporation (NASDAQ:PRCT) is one of the best up and coming stocks to buy according to Wall Street.

As part of its international patient services, LIV Hospital provides coordinated care for individuals travelling for ...